Allogene Therapeutics (ALLO) Stock Price, Quote, News & History | Benzinga

SPY778.28−0.04%QQQ745.98−0.70%BTC/USD82,552.54−1.35%DIA518.25+0.41%GLD382.52−0.54%TLT78.07+0.12%

Allogene Therapeutics Inc (ALLO) Stock Price, Quote, News & History

ALLONASDAQ

Trade with Public

Trade with Public

$1.40

-0.06-4.11%

Last update: Oct 12, 6:08 PM

$1.41

-0.05-3.42%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$1.45

Close

$1.40

Volume / Avg.

4.31M / 5.76M

Day Range

$1.41 - $1.41

52 Wk Range

1.04 - 4.46

Market Cap

$504.42M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

27

Short Interest

17.81%

Days to Cover

9

Recent Allogene Therapeutics, Inc. News

Cellectis Pivots to Gene Editing in Major Overhaul

Cellectis (NASDAQ: CLLS) pivots to in vivo gene editing, extending cash runway to H2 2028. Read pipeline updates on .HEAL-101 & .HEAL-201.

Vandana Singh

Aehr Test Systems, CareDx, Okta And Other Big Stocks Moving Higher On Thursday

U.S. stocks were mixed on Thursday, with the Dow Jones gaining 0.1%. Aehr Test Systems shares rose 15.6% following a $41M production order from an AI customer. Other big gainers include Xanadu Quantum Tech, CareDx Inc, and Nextnav Inc.

Avi Kapoor

Dell To Rally More Than 21%? Here Are 10 Top Analyst Forecasts For Thursday

Analysts change outlook on top names: Mizuho downgrades PYPL, B of A increases CIEN PT, Needham raises TSM PT, HC Wainwright slashes ALLO PT, Goldman raises MS PT, Baird raises WM PT, Bernstein raises INTC PT, B of A raises PNC PT.

Avi Kapoor

Nasdaq Surges 200 Points; Morgan Stanley Posts Upbeat Earnings

US stocks rise, Nasdaq up 200 points; Tech shares lead gains. Morgan Stanley beats estimates. Allbirds up 349%, Snap up 6%. Oil rises 0.7%, gold up 0.1%.

Avi Kapoor

JPMorgan, Allogene Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

US stock futures mixed, Nasdaq 100 up over 50 points. JPMorgan shares down 3.1% after beating earnings but missing sales estimates. Other stocks also down in pre-market trading.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-102.20M

Investing Cash Flow (TTM)

-131.60M

Financing Cash Flow (TTM)

220.09M

Free Cash Flow (TTM)

-102.60M

Capital Expenditure (TTM)

-402.00K

Net Change in Cash (TTM)

-13.71M

Analyst Trends and Forecast

4

3

Apr

0

0

0

0

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$242.17M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

80.07

PB Ratio (TTM)

1.16

Earnings Yield % (TTM)

-45.21%

Earnings Yield % (FWD)

-48.97%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$1.26

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$38.63M

Debt to Equity

0.16

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-